Modulation of nitric oxide improves cyclosporin A-induced hypertension in rats and primates

被引:21
作者
Bartholomeusz, B [1 ]
Hardy, KJ [1 ]
Nelson, AS [1 ]
Phillips, PA [1 ]
机构
[1] Univ Melbourne, Austin & Repatriat Med Ctr, Dept Surg, Heidelberg, Vic 3084, Australia
基金
英国医学研究理事会;
关键词
cyclosporin A; hypertension; bosentan; endothelin; L-arginine; nitric oxide; rats; primates;
D O I
10.1038/sj.jhh.1000709
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Cyclosporin-induced hypertension is a major complication of immunosuppression In transplant recipients but its pathophysiology is only partly understood. Cyclosporin reduces endotheliun-dependent vasodilation and increases endothelin synthesis and release, which may contribute to this hypertension, We examined the effects of: (1) nitric oxide enhancement with L-arginine administration and antagonism with N-nitro-L-arginine; and (2) chronic endothelin receptor blockade with the nan-peptide endothelin receptor antagonist, bosentan, in two animal models of cyclosporin-induced hypertension. Cyclosporin administered daily to female Wistar rats (10 mg/kg per day for 30 days, s,c,) and to marmosets (30 mg/kg per day for 20 days, p,o,) significantly elevated tail cuff systolic blood pressure (BP). L-arginine (250mg/kg, in saline, i,p.), N-nitro-L-arginine (25 mg/kg, in saline, i,p,), bosentan (100 mg/kg, in arabic gum, p.o.) or vehicle were given daily to the rats during the last week of cyclosporin treatment, Marmosets received L-arginine (300 mg/kg, in water, p,o,), bosentan (100 mg/kg/day In arabic gum, p,o,) or vehicle for the last 7 days of cyclosporin treatment. L-arginine, but not saline alone significantly lowered BP in the cyclosporin-hypertensive rats from 129+/-2 mmHg to 122+/-3 mm Hg (P < 0.05), and cyclosporin-hypertensive marmosets from 156 +/- 2 mm Hg to 139 +/- 4 mm Hg (P 0.01). NOLA significantly Increased systolic BP In cyclosporin-treated (from 133 +/- 2 mm Hg at week 3 to 142 +/- 3 mm Hg, P < 0.05) and control rats (from 124.0 +/- 2 mm Hg to 134 +/- 2 mm Hg, P < 0.05) indicating that nitric oxide synthesis in cyclosporin-hypertensive rats could be further antagonised, Bosentan, but not arabic gum alone, also lowered BP in the cyclosporin-hypertensive rats from 134 +/- 1 mm Hg to 122 +/- 3 mm Hg (P < 0.01), and cyclosporin-hypertensive marmosets from 156 2 mm Hg to 139 +/- 4 mm Hg (P < 0.01). These results support the roles of both increased endothelin synthesis and decreased nitric oxide activity in the pathogenesis of cyclosporin A-Induced hypertension.
引用
收藏
页码:839 / 844
页数:6
相关论文
共 28 条
[21]   CYCLOSPORINE-A AND HYPERTENSION [J].
SCHACHTER, M .
JOURNAL OF HYPERTENSION, 1988, 6 (07) :511-516
[22]   ENDOTHELIUM-DEPENDENT RELAXATION IN THE ISOLATED RAT-KIDNEY - IMPAIRMENT BY CYCLOSPORINE-A [J].
STEPHAN, D ;
BILLING, A ;
KRIEGER, JP ;
GRIMA, M ;
FABRE, M ;
HOFNER, M ;
IMBS, JL ;
BARTHELMEBS, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (06) :859-868
[23]   CYCLOSPORINE IMPAIRS RELEASE OF ENDOTHELIUM-DERIVED RELAXING FACTORS IN EPICARDIAL AND RESISTANCE CORONARY-ARTERIES [J].
SUDHIR, K ;
MACGREGOR, JS ;
DEMARCO, T ;
DEGROOT, CJM ;
TAYLOR, RN ;
CHOU, TM ;
YOCK, PG ;
CHATTERJEE, K .
CIRCULATION, 1994, 90 (06) :3018-3023
[24]   STIMULATION OF ENDOTHELIN MESSENGER-RNA AND SECRETION IN HUMAN ENDOTHELIAL-CELLS BY FK-506 [J].
TAKEDA, Y ;
YONEDA, T ;
ITO, Y ;
MIYAMORI, I ;
TAKEDA, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S310-S312
[25]   EFFECTS OF AN ENDOTHELIN RECEPTOR ANTAGONIST IN RATS WITH CYCLOSPORINE-INDUCED HYPERTENSION [J].
TAKEDA, Y ;
MIYAMORI, I ;
WU, PS ;
YONEDA, T ;
FURUKAWA, K ;
TAKEDA, R .
HYPERTENSION, 1995, 26 (06) :932-936
[26]   ENDOTHELIN-1 RELEASE FROM THE MESENTERIC-ARTERIES OF CYCLOSPORINE-TREATED RATS [J].
TAKEDA, Y ;
MIYAMORI, I ;
YONEDA, T ;
TAKEDA, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (03) :445-447
[27]  
VALLANCE P, 1992, LANCET, V339, P572
[28]  
ZOJA C, 1986, LAB INVEST, V55, P455